Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease

This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta111

Important information about this guidance

This guidance has been updated and replaced by NICE technology appraisal 217.